NCT05268822

Brief Summary

Chronic low back pain (CLBP) is a leading disability globally. Exercise therapies are one of the most commonly prescribed treatment options for CLBP. Specific breathing techniques have been shown to enhance brain-based pain modulation and autonomic nervous system balance; these changes have been shown to improve clinical effectiveness in terms of pain management and psychological factors compared to general exercise. However, no previous studies have added a specific breathing technique protocol to an evidence-based exercise program for CLBP.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Feb 2022

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 8, 2022

Completed
Same day until next milestone

Study Start

First participant enrolled

February 8, 2022

Completed
27 days until next milestone

First Posted

Study publicly available on registry

March 7, 2022

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 14, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 14, 2022

Completed
Last Updated

March 9, 2023

Status Verified

March 1, 2023

Enrollment Period

9 months

First QC Date

February 8, 2022

Last Update Submit

March 7, 2023

Conditions

Outcome Measures

Primary Outcomes (10)

  • The numerical pain rating scale (NRPS)

    Eleven-point numerical pain scale. Scale from 0 (no pain) to 10 (worst imaginable)

    Change from Baseline The numerical pain rating scale at 2 months

  • Well-Being in Pain Questionnaire

    Self-developed questionnaire to screen the effects of pain on a person's biopsychosocial well-being. Scale from 0 (no subjective well-being in pain) to 60 (maximum subjective well-being in pain)

    Change from Baseline Well-Being in Pain Questionnaire at 2 months

  • The Roland Morris Disability Questionnaire (RMDQ)

    Questionnaire measuring disability in chronic low back pain populations. Scale from 0 (no disability) to 24 (maximum low back pain related disability)

    Change from Baseline The Roland Morris Disability Questionnaire at 2 months

  • Central Sensitization Inventory (CSI)

    Screening of central sensitization phenomenon. Scale from 0 (no central sensitization) to 100 (worst imaginable central sensitization)

    Change from Baseline Central Sensitization Inventory at two months

  • The 5-level EQ-5D version of the EuroQol

    Health status. Scale from 0 (dead) to 1 (full health)

    Change from Baseline The 5-level EQ-5D version of the EuroQol at 2 months

  • The Generalised Anxiety Disorder Assessment (GAD-7)

    Measure of generalised anxiety disorder related symptoms. Scale from 0 (the most minimal anxiety) to 21 (the most severe anxiety)

    Change from Baseline The Generalised Anxiety Disorder Assessment at two months

  • The Tampa Scale of Kinesiophobia (TSK)

    Assessment of subjective kinesiophobia (fear of movement). Scale from 17 (the minimal kinesophobia) to 68 (the most maximum kinesiophobia).

    Change from Baseline The Tampa scale of Kinesiophobia at two months

  • The Pain Catastrophizing Scale (PCS)

    Assessment of catastrophizing (tendency to magnify the threat value of a pain stimulus) related to pain. Scale from 0 (no catastrophizing thoughts) to 52 (maximum catastrophizing thoughts)

    Change from Baseline he Pain Catastrophizing Scale at two months

  • The Pain and Sleep Questionnaire Three-Item Index (PSQ-3)

    Effect of pain on sleep. Scale from 0 (pain have no any effect on sleep) to 30 (pain have maximum effect on sleep)

    Change from Baseline The Pain and Sleep Questionnaire Three-Item Index at two months

  • The Pain Self-Efficacy Questionnaire (PSEQ)

    assess the self-efficacy of people in pain have in daily activities. The scale is from 0 points (not at all confident) to 6 points (completely confident).

    Change from Baseline The Pain and Sleep Questionnaire Three-Item Index at two months

Secondary Outcomes (3)

  • Feasibility of intervention protocol, recruitment and enrollment

    Through study completion, an average of 2 mothns

  • Responsiveness

    Through study completion, an average of 2 months

  • Quantifying

    Through study completion, an average of 2 months

Study Arms (2)

Movement control exercise with specific breathing techniques

ACTIVE COMPARATOR

Movement control exercise with specific breathing techniques (experimental group)

Other: Home exercise

Movement control exercise without specific breathing techniques

ACTIVE COMPARATOR

Movement control exercise without specific breathing techniques (control group)

Other: Home exercise

Interventions

Movement control exercise with or without specific breathing techniques

Movement control exercise with specific breathing techniquesMovement control exercise without specific breathing techniques

Eligibility Criteria

Age18 Years - 68 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adults aged 18-68-years-old
  • Low back pain lasting more than 3 months (pain sensation more than 3 days per week)
  • A numerical pain scale of more than 3
  • ≥ 2/6 positive low back movement control tests (as described by Luomajoki et al.)
  • Roland-Morris Disability Questionnaire score of five or greater
  • Who are physically able to perform movement control tests and provide written informed consent.

You may not qualify if:

  • Any history of malignant cancer
  • Neurological disease affecting the central nervous system (MS, dementia)
  • Rheumatic disease (fibromyalgia, ankylosing spondylitis/rheumatoid arthritis)
  • Chronic obstructive pulmonary disease,
  • Spinal surgery in the last 12 months
  • A cardiac pacemaker
  • Signs and symptoms of nerve root pathology during the clinic visits.
  • Women who become pregnant during the data collection will also be excluded from the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Private Clinic of principal investigator

Helsinki, Uusimaa, 00100, Finland

Location

Related Publications (2)

  • Mikkonen J, Luomajoki H, Airaksinen O, Goubert L, Pratscher S, Leinonen V. Identical movement control exercises with and without synchronized breathing for chronic non-specific low back pain:A randomized pilot trial. J Back Musculoskelet Rehabil. 2024;37(6):1561-1571. doi: 10.3233/BMR-230413.

  • Mikkonen J, Luomajoki H, Airaksinen O, Goubert L, Leinonen V. Protocol of identical exercise programs with and without specific breathing techniques for the treatment of chronic non-specific low back pain: randomized feasibility trial with two-month follow-up. BMC Musculoskelet Disord. 2023 May 5;24(1):354. doi: 10.1186/s12891-023-06434-6.

Related Links

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: An open-label feasibility study with study subject allocated to movement control exercise with specific breathing techniques (experimental group) or movement control exercise without specific breathing techniques (control group)
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator / PhD student at Institute of Clinical Medicine

Study Record Dates

First Submitted

February 8, 2022

First Posted

March 7, 2022

Study Start

February 8, 2022

Primary Completion

November 14, 2022

Study Completion

November 14, 2022

Last Updated

March 9, 2023

Record last verified: 2023-03

Locations